Cart 2

Navicixizumab (Synonyms: OMP 305B83 [WHO-DD])

Cat.#: 176937

Size:

Special Price 112.9 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Navicixizumab (Synonyms: OMP 305B83 [WHO-DD])
  • Documents
  • Description
    Anti-DLL4 Antibody (Navicixizumab)
  • Tested applications
    ELISA
  • Species reactivity
    Human DLL4
  • Alternative names
    OMP 305B83 [WHO-DD] antibody
  • Isotype
    IgG2SA
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SDS-PAGE

    SDS-PAGE

    Anti-DLL4 Antibody (navicixizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-DLL4 Antibody (navicixizumab) is more than 95%, determined by SEC-HPLC.

    Bioactivity: ELISA

    Bioactivity: ELISA

    Immobilized human VEGF165 His at 2 ug/mL can bind Anti-DLL4 Antibody (navicixizumab), EC50=0.01191 ug/mL.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"